LIMN (STOCKS)
Liminatus Pharma, Inc. Class A Common Stock
$0.123000
+0.001000 (+0.82%)
Prev close: $0.122000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Chris Kim
- Asset Type
- stocks
- Website
- —
Fundamentals
- Market Cap
- $5.61M
- Employees
- 1
- P/E (TTM)
- -0.31
- P/B (TTM)
- -41.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$7.20M |
| Operating Expenses | $3.80M |
| Operating Income/Loss | -$3.80M |
| Income/Loss From Continuing Operations After Tax | -$11.00M |
| Income/Loss From Continuing Operations Before Tax | -$11.00M |
| Net Income/Loss | -$11.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.44 |
| Diluted Earnings Per Share | -$0.44 |
| Basic Average Shares | 87,424,154 |
| Diluted Average Shares | 87,424,154 |
| Assets | $2.79M |
| Current Assets | $2.78M |
| Noncurrent Assets | $11.70K |
| Fixed Assets | $11.70K |
| Liabilities | $2.92M |
| Current Liabilities | $2.89M |
| Noncurrent Liabilities | $33.42K |
| Equity | -$132.60K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$132.60K |
| Liabilities And Equity | $2.79M |
| Net Cash Flow From Operating Activities | -$11.82M |
| Net Cash Flow From Operating Activities, Continuing | -$11.82M |
| Net Cash Flow From Investing Activities | -$1.78M |
| Net Cash Flow From Investing Activities, Continuing | -$1.78M |
| Net Cash Flow From Financing Activities | $13.91M |
| Net Cash Flow From Financing Activities, Continuing | $13.91M |
| Net Cash Flow | $302.73K |
| Net Cash Flow, Continuing | $302.73K |
| Comprehensive Income/Loss | -$11.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.00M |
| Other Comprehensive Income/Loss | $0.00 |